vs

Side-by-side financial comparison of HARROW, INC. (HROW) and PARK NATIONAL CORP (PRK). Click either name above to swap in a different company.

PARK NATIONAL CORP is the larger business by last-quarter revenue ($168.3M vs $89.1M, roughly 1.9× HARROW, INC.). PARK NATIONAL CORP runs the higher net margin — 25.3% vs 7.4%, a 17.9% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 2.2%). PARK NATIONAL CORP produced more free cash flow last quarter ($191.9M vs $8.1M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 4.9%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

National Retail Systems, Inc. (NRS) includes Keystone Freight Corp. & National Retail Transportation, Inc. (NRT). NRS is an asset based 3PL founded in 1952. It is headquartered in Lyndhurst, New Jersey, United States.

HROW vs PRK — Head-to-Head

Bigger by revenue
PRK
PRK
1.9× larger
PRK
$168.3M
$89.1M
HROW
Growing faster (revenue YoY)
HROW
HROW
+31.1% gap
HROW
33.3%
2.2%
PRK
Higher net margin
PRK
PRK
17.9% more per $
PRK
25.3%
7.4%
HROW
More free cash flow
PRK
PRK
$183.9M more FCF
PRK
$191.9M
$8.1M
HROW
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
4.9%
PRK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HROW
HROW
PRK
PRK
Revenue
$89.1M
$168.3M
Net Profit
$6.6M
$42.6M
Gross Margin
79.3%
Operating Margin
17.5%
Net Margin
7.4%
25.3%
Revenue YoY
33.3%
2.2%
Net Profit YoY
-2.2%
10.4%
EPS (diluted)
$0.20
$2.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
PRK
PRK
Q4 25
$89.1M
$168.3M
Q3 25
$71.6M
$169.5M
Q2 25
$63.7M
$168.7M
Q1 25
$47.8M
$157.9M
Q4 24
$66.8M
$164.7M
Q3 24
$49.3M
$170.3M
Q2 24
$48.9M
$157.7M
Q1 24
$34.6M
$152.8M
Net Profit
HROW
HROW
PRK
PRK
Q4 25
$6.6M
$42.6M
Q3 25
$1.0M
$47.2M
Q2 25
$5.0M
$48.1M
Q1 25
$-17.8M
$42.2M
Q4 24
$6.8M
$38.6M
Q3 24
$-4.2M
$38.2M
Q2 24
$-6.5M
$39.4M
Q1 24
$-13.6M
$35.2M
Gross Margin
HROW
HROW
PRK
PRK
Q4 25
79.3%
Q3 25
75.3%
Q2 25
74.5%
Q1 25
67.5%
Q4 24
78.8%
Q3 24
75.6%
Q2 24
74.4%
Q1 24
69.5%
Operating Margin
HROW
HROW
PRK
PRK
Q4 25
17.5%
Q3 25
20.6%
34.3%
Q2 25
17.9%
35.2%
Q1 25
-23.5%
32.4%
Q4 24
19.3%
Q3 24
2.7%
27.4%
Q2 24
3.1%
30.6%
Q1 24
-20.0%
27.8%
Net Margin
HROW
HROW
PRK
PRK
Q4 25
7.4%
25.3%
Q3 25
1.4%
27.8%
Q2 25
7.8%
28.5%
Q1 25
-37.2%
26.7%
Q4 24
10.1%
23.5%
Q3 24
-8.6%
22.4%
Q2 24
-13.2%
25.0%
Q1 24
-39.2%
23.0%
EPS (diluted)
HROW
HROW
PRK
PRK
Q4 25
$0.20
$2.62
Q3 25
$0.03
$2.92
Q2 25
$0.13
$2.97
Q1 25
$-0.50
$2.60
Q4 24
$0.19
$2.38
Q3 24
$-0.12
$2.35
Q2 24
$-0.18
$2.42
Q1 24
$-0.38
$2.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
PRK
PRK
Cash + ST InvestmentsLiquidity on hand
$72.9M
$233.5M
Total DebtLower is stronger
$250.0M
Stockholders' EquityBook value
$52.4M
$1.4B
Total Assets
$399.5M
$9.8B
Debt / EquityLower = less leverage
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
PRK
PRK
Q4 25
$72.9M
$233.5M
Q3 25
$74.3M
$218.9M
Q2 25
$53.0M
$193.1M
Q1 25
$66.7M
$237.6M
Q4 24
$47.2M
$160.6M
Q3 24
$72.6M
$201.7M
Q2 24
$71.0M
$261.5M
Q1 24
$76.0M
$306.1M
Total Debt
HROW
HROW
PRK
PRK
Q4 25
$250.0M
Q3 25
$347.2M
Q2 25
$250.6M
Q1 25
$256.9M
Q4 24
$262.7M
Q3 24
$230.7M
Q2 24
$236.3M
Q1 24
$243.4M
Stockholders' Equity
HROW
HROW
PRK
PRK
Q4 25
$52.4M
$1.4B
Q3 25
$47.0M
$1.3B
Q2 25
$49.7M
$1.3B
Q1 25
$56.5M
$1.3B
Q4 24
$69.7M
$1.2B
Q3 24
$58.0M
$1.2B
Q2 24
$58.5M
$1.2B
Q1 24
$60.6M
$1.2B
Total Assets
HROW
HROW
PRK
PRK
Q4 25
$399.5M
$9.8B
Q3 25
$363.1M
$9.9B
Q2 25
$345.0M
$9.9B
Q1 25
$364.2M
$9.9B
Q4 24
$389.0M
$9.8B
Q3 24
$351.5M
$9.9B
Q2 24
$306.6M
$9.9B
Q1 24
$295.5M
$9.9B
Debt / Equity
HROW
HROW
PRK
PRK
Q4 25
4.77×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
Q4 24
3.77×
Q3 24
3.98×
Q2 24
4.04×
Q1 24
4.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
PRK
PRK
Operating Cash FlowLast quarter
$8.4M
$198.3M
Free Cash FlowOCF − Capex
$8.1M
$191.9M
FCF MarginFCF / Revenue
9.1%
114.1%
Capex IntensityCapex / Revenue
0.4%
3.8%
Cash ConversionOCF / Net Profit
1.27×
4.65×
TTM Free Cash FlowTrailing 4 quarters
$43.0M
$328.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
PRK
PRK
Q4 25
$8.4M
$198.3M
Q3 25
$16.6M
$52.6M
Q2 25
$-803.0K
$49.7M
Q1 25
$19.7M
$37.9M
Q4 24
$-17.8M
$178.8M
Q3 24
$3.0M
$43.8M
Q2 24
$-2.7M
$50.9M
Q1 24
$-4.6M
$35.0M
Free Cash Flow
HROW
HROW
PRK
PRK
Q4 25
$8.1M
$191.9M
Q3 25
$16.4M
$51.1M
Q2 25
$-969.0K
$48.4M
Q1 25
$19.5M
$36.8M
Q4 24
$-18.3M
$169.7M
Q3 24
$2.3M
$41.7M
Q2 24
$-3.1M
$49.0M
Q1 24
$-4.7M
$31.9M
FCF Margin
HROW
HROW
PRK
PRK
Q4 25
9.1%
114.1%
Q3 25
22.9%
30.1%
Q2 25
-1.5%
28.7%
Q1 25
40.8%
23.3%
Q4 24
-27.4%
103.0%
Q3 24
4.8%
24.5%
Q2 24
-6.3%
31.1%
Q1 24
-13.6%
20.8%
Capex Intensity
HROW
HROW
PRK
PRK
Q4 25
0.4%
3.8%
Q3 25
0.3%
0.9%
Q2 25
0.3%
0.8%
Q1 25
0.4%
0.7%
Q4 24
0.8%
5.6%
Q3 24
1.2%
1.2%
Q2 24
0.7%
1.2%
Q1 24
0.3%
2.1%
Cash Conversion
HROW
HROW
PRK
PRK
Q4 25
1.27×
4.65×
Q3 25
16.26×
1.11×
Q2 25
-0.16×
1.03×
Q1 25
0.90×
Q4 24
-2.62×
4.63×
Q3 24
1.14×
Q2 24
1.29×
Q1 24
0.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons